Categories Earnings, Retail

Dean Foods’ stock gains despite wider loss in Q4

Dean Foods Company (DF) reported a higher-than-expected net loss for the fourth quarter of 2018 but revenues came in ahead of expectations. Shares rose 1.3% in premarket hours on Wednesday.

Net sales totaled $1.93 billion, relatively flat compared to the prior-year period.

Net loss attributable to Dean Foods Company was $260.1 million, or $2.85 per share. This compares to a net income of $52.3 million, or $0.57 per share, in the year-ago period. Adjusted EPS from continuing operations was $0.50.

Dean Foods said it has started a review of strategic alternatives to increase shareholder value. The alternatives might include, among others, the disposition of certain assets, the formation of a joint venture, a strategic partnership or even a sale of the company. As the company reviews these alternatives, it has decided to suspend financial guidance.

Dean Foods stock dips on weak Q3 earnings, guidance cut

Dean Foods stated that it has successfully refinanced credit facilities and also decided to suspend its quarterly dividend to enhance financial flexibility.

Capital expenditures totaled $47 million in the fourth quarter. Total outstanding debt at December 31, 2018 was approx. $887 million.

Dean Foods’ rival Campbell Soup Company (CPB) reported second-quarter 2019 results on Wednesday, with both revenue and earnings topping estimates.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Microsoft (MSFT) reports higher revenue and profit for Q3 2024

Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,

GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results

Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was

MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top